Top Industry Leaders in the Meningitis Diagnosis and Treatment Market
Latest Meningitis Diagnosis and Treatment Companies Updates:
Thermo Fisher Scientific Launches QuantiFast™ Singlex PCR Assay for Group B Streptococcus (GBS): This new assay offers rapid and sensitive detection of GBS, a common cause of neonatal meningitis, directly from vaginal swabs.
Abbott Introduces LumiraDx Meningitis Combo Assay: This point-of-care test provides rapid and simultaneous detection of bacterial and viral meningitis in a single test, potentially improving early diagnosis and treatment initiation.
Bio-Rad Laboratories Announces CE-IVD Marking for BioPlex® Pro Meningitis Assays: This expanded panel allows simultaneous detection of multiple meningitis pathogens, streamlining diagnosis and allowing for targeted treatment.
Pfizer Inc. Expands Distribution of Pneumococcal Conjugate Vaccines: This initiative aims to improve access to vaccines preventing pneumococcal meningitis in underserved regions.
List of Meningitis Diagnosis and Treatment Key companies in the market:
- B. Braun Melsungen AG
- Sanofi
- Pfizer Inc.
- Siemens Healthcare Private Limited
- GlaxoSmithKline plc
- Merck KGaA
- Baxter
- Abbott
- Bio-Rad Laboratories Inc.
- Thermo Fisher Scientific Inc.
- Quest Diagnostics Inc.
- Luminex Corporation
- F. Hoffman-La Roche Ltd.
